Editas Medicine
Editas Medicine, based in Cambridge, MA, develops transformative genomic medicines using CRISPR gene editing technology, focusing on ocular diseases, blood diseases, and cancer.
Services
Editas Medicine specializes in developing transformative genomic medicines using CRISPR gene editing technology. The company focuses on creating in vivo gene editing medicines as well as ex vivo gene editing cell medicines. Their approach is designed to deliver novel treatments for serious diseases, aiming to provide new therapeutic options for patients around the world.
Products
Editas Medicine develops a robust pipeline of medicines targeting several critical health conditions. Their product development is particularly focused on ocular diseases, blood diseases, and cancer. Utilizing cutting-edge CRISPR technology, the company strives to bring groundbreaking therapies to market, addressing severe medical needs with innovative genetic approaches.
Corporate Headquarters
Editas Medicine's corporate headquarters are situated in Cambridge, MA. Additionally, the company has a significant and growing site in Boulder, CO, enhancing their research and development capabilities and supporting their mission to advance genomic medicine. These locations form the strategic bases for their scientific and operational initiatives.
Intellectual Property
Editas Medicine holds a substantial portfolio of foundational U.S. and international patents. The company is the exclusive licensee of Harvard University’s and the Broad Institute’s Cas9 and Cas12a patent estates for developing human medicines. This extensive intellectual property portfolio is a critical component of the company's strategy to innovate and lead in the field of genomic medicine.
Community Engagement
Editas Medicine actively engages with the communities for whom they are developing gene editing medicines. The company emphasizes transparency about their scientific endeavors and a responsible approach in their engagements. This commitment to community involvement is a cornerstone of their operational philosophy, ensuring that they remain aligned with the needs and concerns of their target populations.